Market Size of Global Intraoperative Neuromonitoring (IONM) Industry
Study Period | 2019 - 2029 |
Base Year For Estimation | 2023 |
CAGR | 5.10 % |
Fastest Growing Market | Asia Pacific |
Largest Market | North America |
Market Concentration | Low |
Major Players*Disclaimer: Major Players sorted in no particular order |
Need a report that reflects how COVID-19 has impacted this market and its growth?
Intraoperative Neuromonitoring Market Analysis
The intraoperative neuromonitoring (IONM) market is projected to expand at a CAGR of 6.5% over the forecast period, 2022-2027.
The COVID-19 pandemic is expected to have a significant impact on the growth of the brain implants market globally, due to the suspension and postponement of most of the elective surgeries and treatment during the pandemic to reserve the hospital infrastructure and staff for treating COVID-19-infected patients. According to a research article published in medRXiV, 2021, titled 'Covid-19 in Parkinson's Disease Treated by Drugs or Brain Stimulation', the prevalence of SARS-COV2 viral infection in patients with Parkinson's disease was found to be 11.28%. Thus, COVID-19 adversely affected the intraoperative neuromonitoring market. Further, COVID-19 prevalence in Parkinson's disease patients with deep brain stimulation was found to be 18.18%. Additionally, according to a research study published by the Frontiers in Neurology in 2020, titled ''Effects of COVID-19 Lockdown on Movement Disorders Patients With Deep Brain Stimulation: A Multicenter Survey", the motor, and psychiatric symptoms in Parkinson's disease patients and dystonic patients treated with deep brain stimulation were observed to have worsened during the lockdown restriction measures, leading to increased stress in the management of neurological disorders.
The growing prevalence of various lifestyles associated with chronic diseases such as neurological and cardiovascular conditions and increasing emphasis on patient safety during complicated surgeries are some of the factors expected to drive the overall market growth. According to the International Diabetes Federation Diabetes Atlas Tenth edition, updated in December 2021, around 537 million adults all over the world were found to have diabetes in 2021; with the numbers projected to grow to 643 million by 2030 and 783 million by 2045. Moreover, as per the Australian Bureau of Statistics released in March 2022, nearly half of Australians of all ages (46.6%) had one or more chronic conditions, and almost one in five (18.6%) had two or more chronic conditions. Almost half (49.0%) of all females had one or more chronic conditions, and one in five (20.7%) had two or more. Similarly, 43.9% of males had one or more chronic conditions and 16.4% had two or more. This will lead to the increased adoption of intraoperative neuromonitoring which has contributed to the growth of this market.
Intraoperative neuromonitoring (IONM) is a critical technique for monitoring neurosurgery as it offers an early warning concerning motor and sensory functions during surgery by reducing intervention time and risk. As per the Centers for Disease Control and Prevention (CDC) updates from March 2021, each year an estimated 1.5 million Americans sustain a traumatic brain injury (TBI). As a consequence of these injuries: 230,000 people are hospitalized and survive. Thus, with the increasing cases of TBI, the adoption of Intraoperative neuromonitoring is expected to increase over the forecast period.
Moreover, the development of advanced devices, such as neurosurgery devices, surgical microscopes, ophthalmic surgical devices, and surgical robots, has led to a reduction in direct human interference in surgical procedures, which is also expected to support the market growth in the near future. For instance, in October 2020, Medtronic plc received 510(k) clearance from the United States Food and Drug Administration for the NIM Vital nerve monitoring system, which allows physicians to detect, monitor, and confirm nerve function, to assist in reducing the risk of nerve damage during head & neck surgeries.
However, the lack of awareness of IONM in underdeveloped nations and the dearth of skilled personnel restrict the market.
Intraoperative Neuromonitoring Industry Segmentation
Intraoperative neuromonitoring (IONM) is a technique that reduces the risk of neurological deficits during and after surgeries involving the nervous system. An IONM system uses recordings of potentials (such as EEG, EMG, and evoked potentials) from the nervous system during a surgical procedure. The use of neuromonitoring is important during surgeries as it helps in the detection of injuries before they become so severe that they cause postoperative complications in the patients. The Intraoperative Neuromonitoring Market is Segmented by Type (Outsource Monitoring, Insource Monitoring), Application (Spinal Surgery, Ent Surgery, Vascular Surgery, Orthopedic Surgery, Neurosurgery, Other Applications), End User (Hospitals, Ambulatory Surgical Centers), and Geography (North America, Europe, Asia-Pacific, Middle-East and Africa, and South America). The report also covers the estimated market sizes and trends for 17 countries across significant global regions. The report offers the value (in USD million) for the above segments.
BY TYPE | |
Outsource Monitoring | |
Insource Monitoring |
By Application | |
Spinal Surgery | |
Ent Surgery | |
Vascular Surgery | |
Orthopedic Surgery | |
Neurosurgery | |
Other Applications |
By End User | |
Hospitals | |
Ambulatory Surgical Centers |
By Geography | ||||||||
| ||||||||
| ||||||||
| ||||||||
| ||||||||
|
Global Intraoperative Neuromonitoring (IONM) Market Size Summary
The intraoperative neuromonitoring (IONM) market is poised for significant growth, driven by the increasing prevalence of chronic neurological and cardiovascular conditions and the heightened focus on patient safety during complex surgeries. The market's expansion is supported by advancements in surgical technologies and devices that minimize human intervention, thereby enhancing surgical outcomes. Despite the challenges posed by the COVID-19 pandemic, which temporarily disrupted elective surgeries and impacted market growth, the demand for IONM is expected to rise due to the growing incidence of traumatic brain injuries and neurological disorders. The insource IONM segment, in particular, is anticipated to experience substantial growth as it plays a crucial role in monitoring vital functions during surgeries, addressing the rising cases of brain disorders such as Alzheimer's and Parkinson's disease.
North America leads the IONM market, bolstered by the presence of major industry players and favorable reimbursement policies. The region's well-established guidelines and recommendations from neurological centers further support the adoption of IONM, contributing to improved patient outcomes. The increasing burden of neurological conditions, including Alzheimer's, migraines, and strokes, is driving the demand for effective monitoring solutions. The competitive landscape of the market is characterized by dynamic mergers and acquisitions, with both global and local players striving for market penetration. Product innovations and regulatory approvals, such as those by Medtronic and Neurosign, are expected to further propel market growth in the coming years.
Global Intraoperative Neuromonitoring (IONM) Market Size - Table of Contents
-
1. MARKET DYNAMICS
-
1.1 Market Overview
-
1.2 Market Drivers
-
1.2.1 The Rising Incidences of Chronic Diseases due to Lifestyle Changes
-
1.2.2 Risk Management through IONM During Complex Surgeries
-
-
1.3 Market Restraints
-
1.3.1 Low Awareness of IONM in Developing Nations
-
1.3.2 Dearth of Skilled professionals
-
-
1.4 Porter's Five Force Analysis
-
1.4.1 Threat of New Entrants
-
1.4.2 Bargaining Power of Buyers/Consumers
-
1.4.3 Bargaining Power of Suppliers
-
1.4.4 Threat of Substitute Products
-
1.4.5 Intensity of Competitive Rivalry
-
-
-
2. MARKET SEGMENTATION (Market Size by Value - USD million)
-
2.1 BY TYPE
-
2.1.1 Outsource Monitoring
-
2.1.2 Insource Monitoring
-
-
2.2 By Application
-
2.2.1 Spinal Surgery
-
2.2.2 Ent Surgery
-
2.2.3 Vascular Surgery
-
2.2.4 Orthopedic Surgery
-
2.2.5 Neurosurgery
-
2.2.6 Other Applications
-
-
2.3 By End User
-
2.3.1 Hospitals
-
2.3.2 Ambulatory Surgical Centers
-
-
2.4 By Geography
-
2.4.1 North America
-
2.4.1.1 United States
-
2.4.1.2 Canada
-
2.4.1.3 Mexico
-
-
2.4.2 Europe
-
2.4.2.1 Germany
-
2.4.2.2 United Kingdom
-
2.4.2.3 France
-
2.4.2.4 Italy
-
2.4.2.5 Spain
-
2.4.2.6 Rest of Europe
-
-
2.4.3 Asia-Pacific
-
2.4.3.1 China
-
2.4.3.2 Japan
-
2.4.3.3 India
-
2.4.3.4 Australia
-
2.4.3.5 South Korea
-
2.4.3.6 Rest of Asia-Pacific
-
-
2.4.4 Middle-East and Africa
-
2.4.4.1 GCC
-
2.4.4.2 South Africa
-
2.4.4.3 Rest of Middle-East and Africa
-
-
2.4.5 South America
-
2.4.5.1 Brazil
-
2.4.5.2 Argentina
-
2.4.5.3 Rest of South America
-
-
-
Global Intraoperative Neuromonitoring (IONM) Market Size FAQs
What is the current Global Intraoperative Neuromonitoring (IONM) Market size?
The Global Intraoperative Neuromonitoring (IONM) Market is projected to register a CAGR of 5.10% during the forecast period (2024-2029)
Who are the key players in Global Intraoperative Neuromonitoring (IONM) Market?
Accurate Monitoring , Medtronic , NATUS MEDICAL INCORPORATED , Nihon Kohden Corporation and Technomed are the major companies operating in the Global Intraoperative Neuromonitoring (IONM) Market.